Business / Finance

RSS

Heptares, AstraZeneca sign licensing agreement to develop and commercialise immuno-oncology treatments

Heptares Therapeutics, the clinical-stage GPCR structure-guided drug discovery and development company and wholly-owned subsidiary of Sosei Group Corporation, is pleased to announce that it has entered into a licensing agreement with AstraZeneca under which AstraZeneca will acquire exclusive global rights to develop, manufacture and commercialise the adenosine A2A receptor antagonist, HTL-1071, a small molecule immuno-oncology candidate, and potential additional A2A receptor-blocking compounds.

6 Aug 2015

BD reports adjusted revenues of $3.133 billion for third fiscal quarter 2015

BD (Becton, Dickinson and Company), a leading global medical technology company, today reported quarterly adjusted revenues of $3.133 billion for the third fiscal quarter ended June 30, 2015, an increase of 45.2 percent over the prior-year period as reported, or 55.6 percent on a currency-neutral basis. On a comparable, currency-neutral basis, adjusted revenues grew 2.4 percent. As reported, revenues were $3.120 billion.

From BD (Becton, Dickinson and Company) 6 Aug 2015

WI Harper Group announces investment in Cold Genesys

WI Harper Group, a leading US & China, cross-border early growth and expansion stage venture capital firm, today announced an investment in Cold Genesys Inc, a clinical-stage privately-held biotech company developing oncolytic immunotherapies for cancer.

6 Aug 2015

Delcath Systems achieves record quarterly product revenue in Q2 2015

Delcath Systems, Inc., a specialty pharmaceutical and medical device company focused on oncology with an emphasis on the treatment of primary and metastatic liver cancers, announces financial results for the three and six months ended June 30, 2015.

5 Aug 2015

Cardiome Pharma reports net loss of $7.4 million in second quarter 2015

Cardiome Pharma Corp. today reported financial results for the second quarter and six months ended June 30, 2015. Amounts, unless specified otherwise, are expressed in U.S. dollars and in accordance with generally accepted accounting principles used in the United States of America (U.S. GAAP).

5 Aug 2015

Health Care DataWorks acquired by Health Catalyst

Health Catalyst, a leader in healthcare data warehousing, analytics and outcomes improvement, announced today that it has acquired Health Care DataWorks (HCD), a leading provider of business intelligence for health systems.

5 Aug 2015

LifeBond announces closure of $27M Series D preferred equity investment

LifeBond, a leader in the development of bio-surgical medical devices for tissue repair, announced today it has closed a $27M Series D preferred equity investment. Participants in the round include Pitango Venture Capital, Adams Street Partners, Sino Biopharmaceutical Ltd., and all existing investors.

5 Aug 2015

Leidos Holdings reports strong financial results in Q2 2015

Leidos Holdings, Inc., a national security, health and engineering solutions company, today reported financial results for the second quarter of calendar year 2015.

5 Aug 2015

Pharmaxis, Synairgen partner to develop LOXL2 inhibitor to treat idiopathic pulmonary fibrosis

Australian pharmaceutical company Pharmaxis Ltd and UK biotechnology company Synairgen plc today announced they have entered into a research collaboration to develop a selective inhibitor to the lysyl oxidase type 2 enzyme (LOXL2) to treat the fatal lung disease idiopathic pulmonary fibrosis (IPF).

5 Aug 2015

Quest Diagnostics acquires laboratory outreach service business of MemorialCare Health System

Quest Diagnostics, the world's leading provider of diagnostic information services, today announced that it has completed the previously announced acquisition of MemorialCare Health System's laboratory outreach service business.

From Quest Diagnostics 4 Aug 2015

Cardiac Science announces sale of 25 Powerheart G5 AEDs to Lippert Components

Cardiac Science announced the sale of 25 Powerheart G5 automated external defibrillators (AEDs) to Lippert Components, Inc., a tier-1 supplier of parts and accessories to the RV, manufactured housing, trailer, and bus industries.

4 Aug 2015

AMRI’s total revenue increases $89.5 million to 31% in second quarter 2015

AMRI today reported financial and operating results for the second quarter ended June 30, 2015. "We are very pleased to present another strong financial quarter, with all our divisions achieving excellent results," said William S. Marth, AMRI's president and chief executive officer. "Notably, recent acquisitions, combined with the cost reduction initiatives and efficiency efforts we've made to date, are contributing to continued strong contract margin performance.

4 Aug 2015

Halyard Health’s net sales decrease $389 million to 6% in second quarter 2015

Halyard Health, Inc. today reported second quarter 2015 results and updated its net sales and adjusted diluted earnings per share outlook for full-year 2015.

4 Aug 2015

G7 Therapeutics, MorphoSys collaborate on novel antibody therapeutics targeting GPCRs and ion channels

MorphoSys AG and G7 Therapeutics AG announced today that they have signed an agreement to collaborate on novel antibody therapeutics targeting G protein-coupled receptors and potentially other disease-related transmembrane proteins such as ion channels.

4 Aug 2015

Imperial Innovations announces launch of pre-clinical spinout company, Orthonika

Imperial Innovations is pleased to announce the launch of Orthonika, a spinout company from Imperial College London that is developing a novel knee meniscus replacement, MenisciKnit.

4 Aug 2015

Syneron Medical's second quarter 2015 revenue up 14% to $73.5 million

Syneron Medical Ltd., a leading global aesthetic device company, today announced financial results for the three month period ended June 30, 2015.

4 Aug 2015

Capital Impact Partners provides $27.5 million in financing to support underserved communities

Capital Impact Partners announced today that it provided nearly $27.5 million in financing to projects delivering social impact for underserved communities across the U.S. during the second quarter of 2015. These projects are expected to increase access to health care services, dignified aging options, healthy food, and education for low-income people in seven states, while also creating nearly 250 jobs.

4 Aug 2015

FamilyCord announces recent acquisition of LifeLine Cryogenics

California Cryobank Stem Cell Services LLC (dba "FamilyCord"), announced the recent acquisition of LifeLine Cryogenics, an east coast cord blood and reproductive tissue bank primarily servicing the New York tristate area. LifeLine clients will maintain full access to their invaluable tissues, and all prepaid contracts will be honored.

4 Aug 2015

Biosensors’ Q1 FY16 revenue reduces US$67.0M compared to US$80.2M in Q1 FY15

Biosensors International Group, Ltd., a developer, manufacturer and marketer of innovative medical devices, today announced financial results for its first fiscal quarter ended 30 June 2015 ("Q1 FY16").

3 Aug 2015

Array Biopharma reports strong fourth quarter and full year 2015 financial results

Array BioPharma Inc. today reported results for the fourth quarter and full year of its fiscal year ended June 30, 2015.

3 Aug 2015

Business / Finance

Heptares, AstraZeneca sign licensing agreement to develop and commercialise immuno-oncology treatments

BD reports adjusted revenues of $3.133 billion for third fiscal quarter 2015

WI Harper Group announces investment in Cold Genesys

Delcath Systems achieves record quarterly product revenue in Q2 2015

Cardiome Pharma reports net loss of $7.4 million in second quarter 2015

Health Care DataWorks acquired by Health Catalyst

LifeBond announces closure of $27M Series D preferred equity investment

Leidos Holdings reports strong financial results in Q2 2015

Pharmaxis, Synairgen partner to develop LOXL2 inhibitor to treat idiopathic pulmonary fibrosis

Quest Diagnostics acquires laboratory outreach service business of MemorialCare Health System

Cardiac Science announces sale of 25 Powerheart G5 AEDs to Lippert Components

AMRI’s total revenue increases $89.5 million to 31% in second quarter 2015

Halyard Health’s net sales decrease $389 million to 6% in second quarter 2015

G7 Therapeutics, MorphoSys collaborate on novel antibody therapeutics targeting GPCRs and ion channels

Imperial Innovations announces launch of pre-clinical spinout company, Orthonika

Syneron Medical's second quarter 2015 revenue up 14% to $73.5 million

Capital Impact Partners provides $27.5 million in financing to support underserved communities

FamilyCord announces recent acquisition of LifeLine Cryogenics

Biosensors’ Q1 FY16 revenue reduces US$67.0M compared to US$80.2M in Q1 FY15

Array Biopharma reports strong fourth quarter and full year 2015 financial results

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Latest News